Sarilumab (Kevzara) Approved in EU for Rheumatoid Arthritis Sarilumab (Kevzara) Approved in EU for Rheumatoid Arthritis

Sarilumab is indicated for adults with moderate to severe active rheumatoid arthritis who fail or are intolerant to disease-modifying antirheumatic drugs.International Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Rheumatology News Alert Source Type: news